Download PDF
Thromb Haemost 1997; 78(03): 1030-1036
DOI: 10.1055/s-0038-1657682
Rapid Communication
Schattauer GmbH Stuttgart

Synergistic Cofactor Function of Factor V and Protein S to Activated Protein C in the Inactivation of the Factor Villa – Factor IXa Complex

Species Specific Interactions of Components of the Protein C Anticoagulant System
Lei Shea
The Department of Clinical Chemistry, Lund University, the Wallenberg Laboratory, University Hospital, Malmö, Malmö, Sweden
,
Xuhua He
The Department of Clinical Chemistry, Lund University, the Wallenberg Laboratory, University Hospital, Malmö, Malmö, Sweden
,
Björn Dahlbäck
The Department of Clinical Chemistry, Lund University, the Wallenberg Laboratory, University Hospital, Malmö, Malmö, Sweden
› Author Affiliations
Further Information

Publication History

Received 04 1996

Accepted after resubmission 12 May 1997

Publication Date:
12 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

Human factor V has been shown not only to be a precursor to procoagulant factor Va but also to express anticoagulant properties. Thus, factor V was recently found to potentiate the effect of protein S as cofactor to activated protein C (APC) in the inactivation of the factor VIIIa-factor IXa complex. The purpose of this study was to determine whether the APC-cofactor function of factor V was also expressed in the bovine protein C system and to elucidate the molecular background for the species specificity of APC. For this purpose, the effects of protein S and factor V on APC-mediated inactivation of factor VIIIa were studied using purified APC, protein S and factor V of human and bovine.origin. The factor VIIIa investigated here was part of a Xase complex (i.e. factor IXa, factor VIIIa, phospholipid and calcium) and the APC-mediated inhibition of factor VIIIa was monitored by the ability of the Xase complex to activate factor X. Synergistic APC-cofactor function of factor V and protein S was demonstrated in the bovine system. The effect of bovine APC was potentiated by bovine protein S but not by human protein S, whereas both human or bovine protein S stimulated the function of human APC. Factor V did not express species specificity in its APC-cofactor activity even though bovine factor V was more potent than its human counterpart. Recombinant human/bovine protein S chimeras were used to demonstrate that the thrombin sensitive region and first epidermal growth factor-like module of protein S determine the species specificity of the APC-protein S interaction. In conclusion, both human and bovine factor V were found to express APC-cofactor activity which depends on the presence of protein S. The species specificity of APC was shown to be caused by the interaction between APC and protein S.

 

  • References

  • 1 Stenflo J. In: Protein C and related proteins. The Biochemistry of Protein C. Bertina RM. ed. Churchill, Livingtone, Longman Group, UK: 1988. pp. 21-54
  • 2 Esmon CT. The protein C anticoagulant pathway. Arterioscler Thromb 1992; 12: 135-145
    CrossrefPubMedGoogle Scholar
  • 3 Dahlbäck B, Stenflo J. In: The Molecular Basis of Blood Diseases. The Protein C Anticoagulant System. Stamatoyannopoulos G, Nienhuis AW, Majerus PW, Varmus H. eds. WB Saunders; Philadelphia, PA: 1994. pp. 599-628
  • 4 Dahlbäck B. The protein C anticoagulant system: Inherited defects as basis for venous thrombosis. Thromb Res 1995; 77: 01-43
    CrossrefPubMedGoogle Scholar
  • 5 Shen L, Dahlbäck B. Factor V and protein S as synergistic cofactors to activated protein C in degradation of factor VIIIa. J Biol Chem 1994; 269: 18735-18738
    PubMedGoogle Scholar
  • 6 Walker FJ. Regulation of bovine activated protein C by protein S. Thromb Res 1981; 22: 321-327
    CrossrefPubMedGoogle Scholar
  • 7 Weinstein RE, Walker FJ. Enhancement of rabbit protein S anticoagulant cofactor activity in vivo by modulation of the protein S C4b binding protein interaction. J Clin Invest 1990; 86: 1928-1935
    CrossrefPubMedGoogle Scholar
  • 8 He X, Dahlbäck B. Molecular cloning, expression and functional characterization of rabbit anticoagulant vitamin K-dependent protein S. Eur J Biochem 1993; 217: 857-865
    CrossrefPubMedGoogle Scholar
  • 9 Greengard JS, Fernandez JA, Radtke KP, Griffin JH. Identification of candidate residues for interaction of protein S with C4b binding protein and activated protein C. Biochem J 1995; 305: 397-403
    CrossrefPubMedGoogle Scholar
  • 10 Dahlbäck B. Inhibition of protein Ca cofactor function of human and bovine protein S by C4b-binding protein. J Biol Chem 1986; 261: 12022-12027
    PubMedGoogle Scholar
  • 11 Taylor F, Chang A, Esmon CT, D’Angelo A, Vigano-D’Angelo S, Blick KE. Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J Clin Invest 1987; 79: 918-925
    CrossrefPubMedGoogle Scholar
  • 12 He X, Shen L, Dahlbäck B. Expression and functional characterization of chimeras between human and bovine vitamin K-dependent protein S-defining modules important for the species specificity of the activated protein C cofactor activity. Eur J Biochem 1995; 227: 433-440
    CrossrefPubMedGoogle Scholar
  • 13 Dahlbäck B, Hildebrand B, Malm J. Characterization of functionally important domains in vitamin K-dependent protein S using monoclonal antibodies. J Biol Chem 1990; 265: 8127-8135
    PubMedGoogle Scholar
  • 14 Dahlbäck B, Hildebrand B. Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V. Proc Natl Acad Sci USA 1994; 91: 1396-1400
    CrossrefPubMedGoogle Scholar
  • 15 Lamphear BJ, Fay PJ. Factor IXa enhances reconstitution of factor VIIIa from isolated A2 subunit and A1/A3-C1-C2 dimer. J Biol Chem 1992; 267: 3725-3730
    PubMedGoogle Scholar
  • 16 Bakker HM, Tans G, Jansson-Claessen T, Thomassen MC, Hemker HC, Griffin JH, Rosing J. The effect of phospholipids, calcium ions and protein S on rate constants of human factor Va inactivation by activated human protein C. Eur J Biochem 1992; 208: 171-178
    CrossrefPubMedGoogle Scholar
  • 17 Walker FJ, Chavin SI, Fay PJ. Inactivation of factor VIII by activated protein C and protein S. Arch Biochem Biophys 1987; 252: 322-328
    CrossrefPubMedGoogle Scholar
  • 18 Walker FJ, Sexton PW, Esmon CT. The inhibition of blood coagulation by activated Protein C through the selective inactivation of activated Factor V. Biochim Biophys Acta 1979; 571: 333-342
    CrossrefPubMedGoogle Scholar
  • 19 Suzuki K, Stenflo J, Dahlbäck B, Teodorsson B. Inactivation of human coagulation factor V by activated protein C. J Biol Chem 1983; 258: 1914-1920
    PubMedGoogle Scholar
  • 20 Solymoss S, Tucker MM, Tracy PB. Kinetics of inactivation of membranebound factor V by activated protein C. J Biol Chem 1988; 263: 14884-14890
    PubMedGoogle Scholar
  • 21 Kalafatis M, Rand MD, Mann KG. The mechanism of inactivation of human factor V and human factor Va by activated protein C. J Biol Chem 1994; 269: 31869-31880
    PubMedGoogle Scholar
  • 22 Nicolaes GA, Tans G, Thomassen MC, Hemker HC, Pabinger I, Váradi K, Schwarz HP, Rosing J. Peptide bond cleavages and loss of functional activity during inactivation of factor Va and factor VaR506Q by activated protein C. J Biol Chem 1995; 270: 21158-21166
    CrossrefPubMedGoogle Scholar
  • 23 Rosing J, Hoekema L, Nicolaes GA, Thomassen MC, Hemker HC, Varadi K, Schwarz HP, Tans G. Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein C. J Biol Chem 1995; 270: 27852-27858
    CrossrefPubMedGoogle Scholar
  • 24 Fay PJ, Walker FJ. Inactivation of human factor VIII by activated protein C: evidence that the factor VIII light chain contains the activated protein C binding site. Biochim Biophys Acta 1989; 994: 142-148
    CrossrefPubMedGoogle Scholar
  • 25 Regan LM, Lamphear BJ, Huggins CF, Walker FJ, Fay PJ. Factor IXa protects factor VIIIa from activated protein C. Factor IXa inhibits activated protein C-catalyzed cleavage of factor VIIIa at Arg562. J Biol Chem 1994; 269: 9445-9452
    PubMedGoogle Scholar
  • 26 Koedam JA, Meijers JCM, Sixma JJ, Bouma BN. Inactivation of human factor VIII by activated protein C. Cofactor activity of protein S and protective effect of von Willebrand factor. J Clin Invest 1988; 82: 1236-1243
    CrossrefPubMedGoogle Scholar
  • 27 Tracy PB, Peterson JM, Nasheim ME, Mcduffie FC, Mann KG. Interaction of coagulant factor V and factor Va with platelets. J Biol Chem 1979; 254: 10354-10361
    PubMedGoogle Scholar
  • 28 Harris KW, Esmon CT. Protein S is required for bovine platelets to support activated protein C binding and activity. J Biol Chem 1985; 260: 2007-2010
    PubMedGoogle Scholar
  • 29 Hackeng TM, Hessing M, Van’t VeerC, Meijer-Huizinga F, Meijers JC, de Groot PG, van Mourik JABouma BN. Protein S binding to human endothelial cells is required for expression of cofactor activity for activated protein C. J Biol Chem 1993; 268: 3993-4000
    PubMedGoogle Scholar
  • 30 Krishnaswamy S, Williams EB, Mann KG. The binding of activated protein C to factor V and Va. J Biol Chem 1986; 261: 9684-9693
    PubMedGoogle Scholar
  • 31 Walker FJ, Scandella D, Fay PJ. Identification of the binding site for activated protein C on the light chain of factor V and VIII. J Biol Chem 1990; 265: 1484-1489
    PubMedGoogle Scholar
  • 32 Mesters RM, Houghten RA, Griffin JH. Identification of a sequence of human activated protein C (residues 390-404) essential for its anticoagulant activity. J Biol Chem 1991; 266: 24514-24519
    PubMedGoogle Scholar
  • 33 Mesters RM, Heeb MJ, Griffin JH. Interaction and inhibition of blood coagulation factor Va involving residues 311-325 of activated protein C. Protein Sci 1993; 02: 1482-1489
    CrossrefPubMedGoogle Scholar
  • 34 Mesters RM, Heeb MJ, Griffin JH. A novel exosite in the light chain of human activated protein C essential for interaction with blood coagulation factor Va. Biochemistry 1993; 32: 12656-12663
    CrossrefPubMedGoogle Scholar
  • 35 Heeb MJ, Mester RM, Tans G, Rosing J, Griffin JH. Binding of protein S to factor Va associated with inhibition of prothrombinase that is independent of activated protein C. J Biol Chem 1993; 268: 2872-2877
    PubMedGoogle Scholar
  • 36 Heeb MJ, Chang G, Bouma BN, Rosing J, Tans G, Griffin JH. C-terminal residues 621-635 of protein S are essential for binding to factor Va (FVa) but not for factor Xa (FXa). Thromb Haemost 1993; 69: 789
    PubMedGoogle Scholar
  • 37 Lu D, Kalafatis M, Mann KG, Long GL. Comparison of activated protein C/protein S-mediated inactivation of human factor VIII and factor V. Blood 1996; 87: 4708-4717
    PubMedGoogle Scholar
  • 38 Holly RD, Foster DC. Resistance to inhibition by α-1-anti-trypsin and species specificity of a chimeric human/bovine protein C. Biochemistry 1994; 33: 1876-1880
    CrossrefPubMedGoogle Scholar
  • 39 Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de RondeH, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 396: 64-67
    PubMedGoogle Scholar
  • 40 Zöller B, Dahlbäck B. Linkage inherited resistance to activated protein C and factor V gene mutation in venous thrombosis. The Lancet 1994; 343: 1536-1538
    CrossrefPubMedGoogle Scholar
  • 41 Greengard JS, Sun X, Xu X, Fernandez JA, Griffin JH, Evatt B. Activated protein C resistance caused by Arg506Gln mutation in factor Va. The Lancet 1994; 343: 1361-1362
    PubMedGoogle Scholar
  • 42 Voorberg J, Roelse J, Koopman R, Büller H, Berends F, ten Cate JW, Mertens K, van Mourik JA. Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V. The Lancet 1994; 343: 1535-1536
    CrossrefPubMedGoogle Scholar
  • 43 Heeb MJ, Kojima Y, Greengard JS, Griffin JH. Activated protein C resistance: molecular mechanisms based on studies using purified Gln506-factor V. Blood 1995; 85: 3405-3411
    PubMedGoogle Scholar
  • 44 Kalafatis M, Bertina RM, Rand MD, Mann KG. Characterization of the molecular defect in factor VR506Q. J Biol Chem 1995; 270: 4053-4057
    CrossrefPubMedGoogle Scholar
  • 45 Aparicio C, Dahlbäck B. Molecular mechanisms of activated protein C resistance. Properties of factor V isolated from an individual with homozygosity from the Arg506 to Gin mutation in the factor V gene. Biochem J 1996; 313: 467-472
    CrossrefPubMedGoogle Scholar
  • 46 Váradi K, Rosing J, Tans G, Pabinger I, Keil B, Schwarz HP. Factor V enhances the cofactor function of protein S in the APC-mediated inactivation of factor VIII: influence of the factor VR506Q mutation. Thromb Haemost 1996; 76: 208-214
    Article in Thieme ConnectPubMedGoogle Scholar